The PCR-based detection of a broad range of bacteria is widely applied for the screening of clinical, environmental, and manufacturing samples to diagnose infectious diseases or to detect a bacterial contamination. If bacterial species are unknown, a broad range of bacteria can be detected by using bacterial universal primers targeting highly conserved regions in the bacterial 16S rRNA gene (24) . In cases where bacterial DNA is detected, it can be further characterized by DNA sequencing (16) , sequence-specific hybridization (15) , or other methods, including size-dependent electrophoretic separation (8) , a restriction fragment length polymorphism analysis (13) , pyrosequencing (10), a single-strand conformation polymorphism analysis (7) , and mass spectrometry (14) . As PCR is capable of 10 6 -to 10 7 -fold amplification of a single copy of template DNA, PCR may enable the identification of bacterial DNA even in some culture-negative samples and can provide more rapid diagnostic results than culture analysis in emergency situations, such as septic shock (11) . However, the validity of bacterial universal PCRs is compromised by unclear results, especially when amplifying a small amount of bacterial DNA (26) .
Concerning bacterial universal PCRs, the main problem is the achievement of sensitive and reliable detection of bacteria with a clear negative control. Over the years, this has been an unsolved problem, because the reagents used in the PCR process are contaminated with trace amounts of bacterial DNA, especially the thermostable DNA polymerase (e.g., Taq polymerase) (2, 9, 16, 20) . Whenever target DNA is present in very small quantities, contaminating DNA becomes a major problem, since even low-copy-number contamination will be amplified, thus leading to problems in obtaining low detection limits.
A number of studies have indicated the presence of contaminating bacterial DNA in commercial preparations of recombinant thermostable DNA polymerases as a result of its manufacture and incomplete purification (2, 9, 16, 20) . Estimates of contamination in commercially available lots of thermostable DNA polymerases range from 10 2 to 10 5 genome equivalents of bacterial DNA per unit of enzyme (2, 16, 20) . Although thermostable DNA polymerase is usually manufactured using Escherichia coli, the contaminating DNA is not always originated from host cells but from multiple bacterial sources (9, 20) . Our experiments indicated that the contaminating bacterial DNA is traced mainly from bacterial host cells, with a small amount of multiple bacteria (data not shown).
No universally applicable method for completely removing bacterial DNA from thermostable DNA polymerase preparations has been established (2, 19) . Removal of DNA contamination from thermostable DNA polymerase has been approached by physical, chemical, and enzymatic treatments using UV irradiation (18) , psoralens with long-wave UV light (9, 16) , ethidium monoazide treatment (22), restriction endonuclease digestion (1, 17) , ultrafiltration (17) , and digestion with DNase I (5, 21) . These methods have been tested individually, and inconsistent decontamination results have been reported for all of them (2, 12, 19) . In fact, Philipp et al. reported that they were unable to achieve an improvement in sensitivity lower than that obtained for a concentration of 2,500 bacterial CFU/ml sample material using restriction enzymes and microfiltration (19) . Furthermore, most of the decontamination procedures lead to a decreased performance of the thermostable DNA polymerase (2, 12) . Therefore, reliable and efficient decontamination methods need to be developed.
To resolve the problem, we propose a novel approach to make thermostable DNA polymerase free from bacterial DNA contamination.
MATERIALS AND METHODS
Manufacturing of Taq polymerase by using Saccharomyces cerevisiae (yeast) cells. Restriction enzymes and the ligation kit were purchased from Takara Bio (Shiga, Japan). The pYES2 vector and custom primers were purchased from Invitrogen (Carlsbad, CA). S. cerevisiae strain ϫ2180-1A (ATCC 204504) was obtained from the ATCC (Manassas, VA). Yeast extract, peptone, yeast nitrogen base, and Casamino Acids were obtained from Difco (Detroit, MI). The transformation kit was purchased from ZYMO Research (Orange, CA). SYBR Green I was purchased from Sigma-Aldrich (Milwaukee, WI). Dimethyl sulfoxide (DMSO) was purchased from Kanto Chemical (Tokyo, Japan). M13mp18 singlestranded DNA was purchased from Bayou Biolabs (Harahan, LA). dATP, dGTP, dCTP, and dTTP were obtained from PerkinElmer (Norwalk, CT). Nonidet P-40 was purchased from MP Biomedicals (Aurora, OH). All other reagents were obtained from Wako Pure Chemical Industries (Osaka, Japan).
The Taq polymerase gene (AB609596) with optimized codon usage for expression in Saccharomyces cerevisiae was chemically synthesized with an HindIII site at the 5Ј end and an EcoRI site at the 3Ј end and inserted into the pUC57 plasmid, pUC-TA01, from the GenScript Corporation (Piscataway, NJ). The pUC-TA01 vector was double digested with HindIII and EcoRI and subsequently inserted into the HindIII-EcoRI sites of the pYES2 vector, pYES-TA01, using a DNA ligation kit, version 2.1.
The pYES-TA01 vector was transformed into the S. cerevisiae strain ϫ2180-1A (ura3-52) using a Frozen-EZ Yeast Transformation II kit. The colonies of the pYES-TA01 transformant were selected by SD medium containing 0.17% yeast nitrogen base without amino acids and ammonium sulfate, 0.5% ammonium sulfate, 2% glucose, and 2% agarose. Isolated colonies were used for the expression of the Taq polymerase gene by culturing them in 250 ml of SC-galactose medium containing 0.17% yeast nitrogen base without amino acids and ammonium sulfate, 0.5% ammonium sulfate, 2% galactose, 0.2% dropout powder (2 g Casamino Acids, 20 mg adenine, 20 mg tryptophan), 100 mg/liter gentamicin, and 50 mg/liter kanamycin at 28°C for 72 h. Following centrifugation at 5,000 rpm for 10 min, yeast cells were washed with water several times and then resuspended in lysis buffer containing 50 mM Tris-HCl (pH 7.5) and 50 mM KCl.
Three grams of yeast cells in 3 ml of ice-cold lysis buffer was agitated by a vortex mixer vigorously at 4°C with 6 g of glass beads (0.5 mm; TOMY, Tokyo, Japan). After the centrifugation of the cell lysate at 12,000 rpm for 20 min, the insoluble fraction was resuspended in 30 ml of lysis buffer and then heat treated at 70°C for 60 min. After that, the heat-treated solution was centrifuged at 12,000 rpm for 20 min, and the supernatant was applied to a 15-ml column of HiTrap Q HP (GE Healthcare, Piscataway, NJ) equilibrated with 50 ml of 50 mM Tris-HCl, pH 7.5. Elution of the Taq polymerase fraction was achieved with 50 ml of 50 mM Tris-HCl buffer, pH 7.5, containing 150 mM NaCl. The eluted fraction was applied to a 5-ml column of HiTrap heparin HP (GE Healthcare) equilibrated with 50 ml of 50 mM Tris-HCl, pH 7.5, and the Taq polymerase fraction was eluted with 25 ml of 50 mM Tris-HCl buffer, pH 7.5, containing 400 mM NaCl. The target fraction was concentrated and exchanged into the stock buffer solution containing 20 mM Tris-HCl, pH 7.5, 100 mM KCl, 1 mM dithiothreitol (DTT), 0.1 mM EDTA, 0.5% NP-40, 0.5% Tween 20, and 50% glycerol, by an Amicon Ultra PL-50 filter (Millipore, Milford, MA) in order to obtain the final Taq polymerase concentration of 0.1 to 1.0 mg/ml.
The activity of Taq polymerase was determined by a fluorescence-based DNA polymerase assay described previously (23) . First, the reaction mixture stock solution containing 14 pmol of M13mp18 DNA and 24 pmol of primer (5Ј-TT CCCAGTCACGACGTTGTAAAACGACGGCCAGTG-3Ј) in 10 mM TrisHCl (pH 8.8), 50 mM KCl, 0.08% Nonidet P-40, and 2 mM MgCl 2 was mixed and heated at 70°C for 5 min and then cooled to room temperature over 20 min. For the assay, the reaction solution containing 1.2 l of reaction mixture stock solution, 5 l of 2 mM (each) dATP, dCTP, dGTP, and dTTP, 2.5 l of 10ϫ reaction buffer, and 15.3 l of water deionized and sterilized for molecular biology was preheated at 74°C, and the reaction was started by the addition of 1 l DNA polymerase. After the incubation at 74°C for 5 min, the reaction was stopped by the addition of 50 l 50 mM EDTA, followed by 15 l of water and 10 l of 100ϫ SYBR green I solution diluted with DMSO. After 5 min, the fluorescence in the reaction mixture was measured in a POWERSCAN HT microplate reader (DS Pharma Biomedical, Osaka, Japan) at 528 nm, using an excitation wavelength of 497 nm. The units of yeast-made Taq polymerase were determined by comparison to the standard curve of enzyme units by use of a commercially available Taq polymerase.
Manufacturing of Taq polymerase by using tobacco cultured BY-2 (plant) cells. The Taq polymerase was produced in cultured BY-2 cells using a tomato mosaic virus (ToMV)-based expression vector and the inducible virus infection system (3, 4) . The ToMV vector for expression of each recombinant protein was constructed using pBICER8-ToMV-C0.3-HuIFN-␥-SRz22 (4) by replacing the IFN-␥ gene with the codon-optimized synthesized DNA encoding the Taq polymerase (AB609597). The construct was introduced into the transgenic BY-2 cells expressing the estrogen-activatable transcription factor, XVE. Induction by ␤-estradiol was performed essentially according to reference 3 except for culturing the BY-2 cells with the Taq polymerase gene in medium containing 25 and 50 mg/liter hygromycin and kanamycin, respectively.
A total of 30 ml of the cell cultures was centrifuged for 3 min at 800 rpm. The pellets containing Taq polymerase were frozen at Ϫ70°C, and the pellet was sonicated in 15 ml of lysis buffer for 3 min and incubated at 70°C for 60 min. The extract was centrifuged for 10 min at 30,000 ϫ g, and the supernatant was used for PCRs.
Commercially available thermostable DNA polymerases. The following Taq polymerases from commercial vendors designed for PCR were used in the experiments reported here as companies A to H: A, Crimson Taq DNA polymerase (New England BioLabs, MA; lot number 8000912); B, GoTaq Flexi DNA polymerase (Promega, WI; lot number 28512819); C, Red Taq genomic DNA polymerase (Sigma-Aldorich, MO; lot number 20K9010); D, AmpliTaq Gold LD (ABI, CA; lot number 1005027); E, EX Taq (TaKaRa, Kyoto, Japan; lot number KA3401CA); F, r-Taq DNA polymerase (Toyobo, Osaka, Japan; lot number 93522G6); G, Platinum Taq DNA polymerase high fidelity (Invitrogen, CA; lot number 851727); H, native Pfu DNA polymerase (Stratagene, CA; lot number 6045339).
DNA isolation. The following water samples were used in the experiments reported herein as samples A to D: A, tap water from Toyama University Hospital (Toyama City, Japan); B, URIWARI-SHOUZU spring water (drinking water) obtained from Tonami City, Japan; C, Shougawa district hot spring water from Tonami City, Japan; and D, circulating water for air conditioning from Toyama University Hospital (Toyama City, Japan). These water samples (50 ml) were centrifuged at 13,000 ϫ g for 20 min, and the resulting pellets were used for the analysis. DNA was isolated from the pellets using a DNA extraction kit (InstaGene matrix; Bio-Rad Laboratories, CA) in accordance with the supplier's instructions.
Venous blood samples used in the experiments reported herein were as follows: A, blood from one healthy person; B, blood from one patient with septicemia, who had a blood culture positive for Bacillus cereus; C, blood from one patient with septicemia, who had a blood culture positive for Candida albicans. These venous blood samples (2 ml) were collected in EDTA-2K after informed consent had been obtained. Blood samples were centrifuged at 130 ϫ g for 2 min to spin down the blood cells, and the resulting supernatant fractions were used. The supernatants were centrifuged again at 10,000 ϫ g for 2 min, and DNA was isolated from the resulting pellets using a DNA extraction kit (InstaGene matrix; Bio-Rad Laboratories, CA) in accordance with the supplier's instructions.
PCR assays. A common PCR buffer was prepared to test all Taq polymerases. The PCR mixture (20 l) contained 1 l of DNA template or 1 l (80 ng/ml) of DNA extracted from Escherichia coli (ATCC 25922) as a positive control or distilled water (water deionized and sterilized for molecular biology; Nakalai Tesque, Inc., Kyoto, Japan) as a negative control in 50 mM KCl, 1.5 mM MgCl 2 , 10 mM Tris-HCl (pH 8.0 to 8.9), 200 M each deoxynucleoside triphosphate (dNTP), 0.5 M each primer, and 2.5 units (0.5 to 2.5 l) of thermostable DNA polymerase supplemented with storage buffer. We used 1.5-ml or 0.2-ml graduated microcentrifuge tubes with flat-top caps that were RNase and DNase free (Quality Scientific Plastics).
All oligonucleotide primers were synthesized by Hokkaido System Science Co., Ltd. (Hokkaido, Japan). Primers were designed to universally amplify 287 bp of bacterial 16S rRNA genes (forward, 5Ј-AGCAGCCGCGGTAATA-3Ј; reverse, 5Ј-GGACTACCAGGGTATCTAATCCT-3Ј) and to universally amplify 146 bp of fungal 18S rRNA genes (forward, 5Ј-ATACCGTCGTAGTCTTAAC CA-3Ј; reverse, 5Ј-GTCAATTCCTTTAAGTTTCAGCCT-3Ј).
The mixture was subjected to a total of 30, 40, 60, or 100 cycles of PCR amplification. Those samples were denatured for 30 s at 95°C, annealed for 30 s at 55°C, and subjected to extension for 60 s at 68 to 72°C with a thermal cycler (Gene Amp 2400-R; PerkinElmer). Amplicons were further analyzed by gel electrophoresis (2% agarose gel, ethidium bromide staining).
Sequencing of contaminants. Amplicons were purified from samples or negative PCR controls (QIAquick PCR purification kit; Qiagen) and sequenced (310 genetic analyzer; Applied Biosystems) using the forward primer of the amplification reactions. An online homology search was performed for strain identification using the BLAST nucleotide database tool (http://www.ncbi.nlm.nih.gov/).
RESULTS AND DISCUSSION
At the beginning, we confirmed the presence of contaminating bacterial DNA in commercial thermostable DNA polymerases from eight companies (A to H) using bacterial universal primers (Fig. 1a) . All these polymerases were rec-VOL. 49, 2011 NOVEL POLYMERASE FREE FROM BACTERIAL DNA CONTAMINATION 3317 ognized to have contamination by bacterial DNA, at least after 40 cycles of PCR amplification. The commercial thermostable DNA polymerase of company D is marketed as a low-DNA (LD) Taq polymerase, which is purified by an additional separation process to eliminate contaminating bacterial DNA from the enzyme preparation. However, contaminating bacterial DNA was still recognized in the LD Taq polymerase, as has been reported several times by other authors (2, 9, 16) . To achieve the production of thermostable DNA polymerase free from bacterial DNA contamination, we developed a new eukaryote-made thermostable DNA polymerase, which is a recombinant Taq polymerase manufactured using eukaryotic host cells. For the eukaryotic cells, we utilized yeast (Saccharomyces cerevisiae) and plant (tobaccocultured BY-2) cells. There are two advantages of this strategy to prevent false-positive results. First, although this eukaryote-made thermostable DNA polymerase may contain trace amounts of DNA from eukaryotic host cells as a result of its incomplete purification, no bacterial universal primers can bind to eukaryotic genomic DNA, because the base sequences between bacteria and eukaryotes are quite different. According to the universal phylogenetic tree determined from rRNA sequence comparisons, there are large sequence distances between eubacteria and eukaryotes (25) . Second, as eukaryotic host cells are used, antibacterial drugs can be used during the steps of manufacturing the recombinant thermostable DNA polymerases. Consequently, contaminating bacteria can be blocked. However, as antibacterial drugs inhibit or kill bacteria but do not eliminate their DNA, it is therefore necessary to use antibacterial drugs as soon as the eukaryotic host cells start to grow. No similar approach has been reported before.
To demonstrate the advantages of using this new method, we confirmed the nonexistence of contaminating bacterial DNA in yeast-made and plant-made Taq polymerase using bacterial universal primers (Fig. 1b) . No contaminating bacterial DNA was detected, even after 100 cycles of PCR amplification, which indicates that the sensitive and reliable detection of bacteria without any unclear results is feasible using eukaryote-made thermostable DNA polymerase.
As a practical example, we performed a sensitive PCR assay (60 cycles) for bacterial contamination of household water using bacterial universal primers (Fig. 2a) . Unlike conventional bacterially made Taq polymerase, eukaryotemade Taq polymerase does not detect any contaminating bacterial DNA, and so a very low abundance of bacteria in hot spring water could thus be reliably detected (Fig. 2a,  sample C) . The amplicon that appeared in hot spring water was subjected to a sequencing analysis and was identified as Pseudomonas alcaligenes (data not shown).
Pathogenic bacteria are the most frequent causes of septicemia, but fungi can also be isolated in a minority of patients (6) . Indeed clinical laboratories do not usually perform PCR directly on blood to identify either bacterial or fungal pathogens, but we would like to propose the possibility of conducting the PCR-based detection of pathogens.
To prevent the occurrence of unclear results in PCR-based assaying of clinical samples for both bacterial and fungal pathogens, a two-step usage of thermostable DNA polymerases is recommended. That is, to detect bacterial pathogens, eukaryote-made thermostable DNA polymerase can be used in combination with bacterial universal primers. In contrast, to detect fungal pathogens, conventional bacterially made thermostable DNA polymerase, which is usually free from fungal DNA contamination, can be used in combination with fungal universal primers (Fig. 2b) . Although bacterially made thermostable DNA polymerase contains trace amounts of DNA from bacterial host cells, no fungal universal primers can bind to bacterial genomic DNA, because fungi are eukaryotes. Consequently, the sensitive and reliable detection of bacteria and fungi without any unclear results would make it possible to obtain more accurate diagnostic results, which would thereby improve both disease surveillance and patient management.
In conclusion, we demonstrated that the eukaryote-made thermostable DNA polymerase solves the problem of contaminating bacterial DNA in conventional bacterially made thermostable DNA polymerase, which has been unsolved for many years. Using eukaryote-made thermostable DNA polymerase, the sensitive and reliable detection of bacteria becomes feasible in practice for various fields, e.g., medicine, livestock raising, household water, purified water used in pharmaceutical manufacturing processes, food products, cell culture infection, and research in microbiology, etc. This achievement is therefore expected to enable the development of a wide range of powerful applications. 
